FDA and the regulation of medical software

This paper traces the development of the Food and Drug Administration's (FDA) regulation of computer software, as discrete products with medical applications as well as components of regulated medical devices. The earliest Agency deliberations of software are summarized, as are the Agency's broad policy priorities and the concerns of developers, medical industries, and user communities over the potential scope and consequences of FDA regulation.<
>